TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31861714

Group type: EXPERIMENTAL
Intervention: Lumbar lordotic curve-controlled traction (L-LCCT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional traction (TT)
Number of subjects: 40
Study: 29656145

Group type: EXPERIMENTAL
Intervention: 12 SQ‐HDM
Number of subjects: 2138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2138
Study: 27812637

Group type: EXPERIMENTAL
Intervention: Tiotropium 5 µg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Indacaterol 150 µg
Number of subjects: 20
Study: 24262762

Group type: EXPERIMENTAL
Intervention: Anakinra 100 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 22582889

Group type: EXPERIMENTAL
Intervention: Training under a mentor for 2 hours
Number of subjects: 36

Group type: COMPARATOR
Intervention: Training without a mentor for 2 hours
Number of subjects: 36
Study: 20678621

Group type: EXPERIMENTAL
Intervention: Laparoscopic repair
Number of subjects: 1542

Group type: COMPARATOR
Intervention: Open mesh repair (Lichtenstein group)
Number of subjects: 1542
Study: 17377602

Group type: EXPERIMENTAL
Intervention: Revascularization
Number of subjects: 731

Group type: COMPARATOR
Intervention: Medical management alone
Number of subjects: 731
Study: 11052900

Group type: EXPERIMENTAL
Intervention: Median nerve mobilization
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Carpal bone mobilization
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 21
Study: 9444800

Group type: EXPERIMENTAL
Intervention: 150 mg prolonged-release capsule per day
Number of subjects: 40

Group type: COMPARATOR
Intervention: 50 mg enteric-coated tablet every 8 hours
Number of subjects: 40
Study: 8154260

Group type: EXPERIMENTAL
Intervention: Daily dietary supplement of a mixture consisting of vitamins (A, B1, B2, B6, E) and trace elements (calcium, iron, manganese)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Daily dietary supplement of purely vitamin C tablets
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (1/3 of subjects)
Number of subjects: 60
Study: 2876233

Group type: EXPERIMENTAL
Intervention: Higher-dose frusemide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 10
Study: 29851760

Group type: EXPERIMENTAL
Intervention: 25 μg vitamin D supplements
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: 10 μg vitamin D supplements
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo (2 μg)
Number of subjects: 206
Study: 26099215

Group type: EXPERIMENTAL
Intervention: Riluzole 100 mg BID for the first 24 hours followed by 50 mg BID for the following 13 days
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study: 24101016

Group type: EXPERIMENTAL
Intervention: Minimally invasive esophagectomy (MIE)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional open esophagectomy (OE)
Number of subjects: 27
Study: 23952183

Group type: EXPERIMENTAL
Intervention: Telemental health (TMH) intervention, average of 5.3 of 6.0 planned sessions completed.
Number of subjects: 223

Group type: COMPARATOR
Intervention: Control group (TMH consultation), 96% completed a TMH consultation.
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Both groups completed an average of 4.8 of the 5.0 assessments.
Number of subjects: 223
Study: 19488796

Group type: EXPERIMENTAL
Intervention: 500 ppm fluoride dentifrice
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 1,000 ppm fluoride dentifrice
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 1,500 ppm fluoride dentifrice
Number of subjects: 72

Group type: COMPARATOR
Intervention: 0 ppm fluoride dentifrice
Number of subjects: 72

Group type: COMPARATOR
Intervention: 250 ppm fluoride dentifrice
Number of subjects: 72
Study: 18786088

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 40
Study: 16670161

Group type: EXPERIMENTAL
Intervention: T(4) dosage adjustment aiming for serum TSH concentration less than 2 mU/liter
Number of subjects: 56

Group type: COMPARATOR
Intervention: T(4) dosage adjustment aiming for serum TSH concentration in the upper reference range
Number of subjects: 56
Study: 12786770

Group type: EXPERIMENTAL
Intervention: Fexofenadine b.i.d. with nedocromil rescue
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Fexofenadine q.d. with nedocromil b.i.d.
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Fexofenadine rescue with nedocromil b.i.d.
Number of subjects: 89

Group type: COMPARATOR
Intervention: All regimens
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Lower fexofenadine dosages with nedocromil b.i.d.
Number of subjects: 89
Study: 11512311

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) as part of immunosuppression therapy
Number of subjects: 367

Group type: COMPARATOR
Intervention: Azathioprine as part of immunosuppression therapy
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty and stenting of posttransplant renal artery stenosis
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Doppler ultrasound scanning
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA)
Number of subjects: 367
Study: 8863274

Group type: EXPERIMENTAL
Intervention: 0.1% oral rinse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% oral rinse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.01% oral rinse
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10 mg peroral ketorolac capsule
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1.0% dentifrice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.15% dentifrice
Number of subjects: 0
Study: 1371550

Group type: EXPERIMENTAL
Intervention: Balloon dilation of the prostate
Number of subjects: 33

Group type: COMPARATOR
Intervention: Cystoscopy
Number of subjects: 33
Study: 31264800

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy for Children (MBCT-C)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 24
Study: 30149341

Group type: EXPERIMENTAL
Intervention: Personal PM2.5 exposure measured using low-cost personal monitors over one week (five weekdays and one weekend)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Personal PM2.5 exposure measured during weekdays and weekends
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Personal PM2.5 exposure in relation to distance from roads
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Personal PM2.5 exposure in relation to open space
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Community perception of air pollution exposure
Number of subjects: 14
Study: 26541906

Group type: EXPERIMENTAL
Intervention: Swimming exercise
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cycling training
Number of subjects: 48
Study: 24068549

Group type: EXPERIMENTAL
Intervention: Fast-track surgery (FTS)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional pathway (control)
Number of subjects: 68
Study: 22135277

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg p.o. q.d. for 5 days
Number of subjects: 1056

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanic acid 875/125 mg p.o. b.i.d. for 7 days
Number of subjects: 1056

Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 1056

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanic acid
Number of subjects: 1056
Study: 20568520

Group type: EXPERIMENTAL
Intervention: Muscle-derived stem cells (MDSCs) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mesenchymal stem cells (MSCs) therapy
Number of subjects: 0
Study: 18263901

Group type: EXPERIMENTAL
Intervention: Stepped care (feedback, manual, and up to three counselling sessions)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Fixed care (four sessions)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Stepped care
Number of subjects: 408
Study: 16873343

Group type: EXPERIMENTAL
Intervention: Nabilone 2 mg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Nabilone 1 mg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Ketoprofen 50 mg
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 12903037

Group type: EXPERIMENTAL
Intervention: 6 short tandem repeat (STR) loci on chromosome 7p14-15
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 8 short tandem repeat (STR) loci on chromosome 12q13
Number of subjects: 100
Study: 10799631

Group type: EXPERIMENTAL
Intervention: 3.5 mL of undiluted albuterol nebulized for 20 inhalations every 20 minutes for a total of 3 treatments.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Albuterol diluted (0.5 mL) and nebulized in normal saline (3 mL) every 20 minutes for a total of 3 treatments.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Study group (undiluted albuterol)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (diluted albuterol)
Number of subjects: 50
Study: 8967585

Group type: EXPERIMENTAL
Intervention: Propofol and fentanyl
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard isoflurane anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isoflurane using a low-flow system (fresh gas flow 2 l/min)
Number of subjects: 60
Study: 1640029

Group type: COMPARATOR
Intervention: Gentamicin via the endotracheal tube
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined approach (SDD) of oropharyngeal, gastrointestinal and parenteral use of certain antibiotics
Number of subjects: 0
Study: 6150321

Group type: EXPERIMENTAL
Intervention: Plasma exchange
Number of subjects: 38
Study: 30991815

Group type: EXPERIMENTAL
Intervention: Topical ciprofloxacin (intraoperative plus 5 days)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Normal saline (intraoperative plus 5 days)
Number of subjects: 200
Study: 29974433

Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablets (FBT) 100 μg (group A)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablets (FBT) 200 μg (group B)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablets (FBT)
Number of subjects: 66
Study: 26340704

Group type: EXPERIMENTAL
Intervention: Insulin Detemir
Number of subjects: 56
Study: 24271646

Group type: EXPERIMENTAL
Intervention: Opicapone (50 mg oral dose) in patients with moderate liver impairment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Opicapone (50 mg oral dose) in healthy subjects (control)
Number of subjects: 16
Study: 23022943

Group type: EXPERIMENTAL
Intervention: Miracle Fruit™ supplement
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 19460960

Group type: EXPERIMENTAL
Intervention: Iodized salt (150-250 microg/d for adults)
Number of subjects: 2000000000

Group type: EXPERIMENTAL
Intervention: Universal salt iodization
Number of subjects: 2000000000

Group type: EXPERIMENTAL
Intervention: Iodine supplementation during pregnancy
Number of subjects: 2000000000

Group type: EXPERIMENTAL
Intervention: Povidone-iodine disinfectants
Number of subjects: 2000000000

Group type: EXPERIMENTAL
Intervention: Introduction of iodized salt
Number of subjects: 2000000000
Study: 18070735

Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy
Number of subjects: 375

Group type: COMPARATOR
Intervention: Delayed laparoscopic cholecystectomy
Number of subjects: 375
Study: 15674406

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Spironolactone (25 mg/day)
Number of subjects: 50
Study: 12375237

Group type: EXPERIMENTAL
Intervention: Cruciate-retaining (CR) total knee arthroplasty (NexGen, Zimmer, Warsaw, IN)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Posterior-stabilized (PS) total knee arthroplasty (Legacy PS, Zimmer, Warsaw, IN)
Number of subjects: 40
Study: 10545689

Group type: EXPERIMENTAL
Intervention: NIHSS administered by neurologists
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: NIHSS administered by research nurses
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: NIHSS administered by research nurses and neurologists
Number of subjects: 31
Study: 8779650

Group type: EXPERIMENTAL
Intervention: Vitamin supplementation in cases of initially insufficient vitamin supply
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supplemental vitamin intake in physiological dosages in addition to a vitamin-sufficient diet
Number of subjects: 0
Study: 2225500

Group type: EXPERIMENTAL
Intervention: High-frequency emphasis commercial aid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard NHS contracted hearing aid
Number of subjects: 0
Study: 376210

Group type: EXPERIMENTAL
Intervention: Clonidine three times a day with a diuretic
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Clonidine twice a day with a diuretic
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 18
Study: 30739176

Group type: EXPERIMENTAL
Intervention: Ectoine lozenges
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid lozenges
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline gargle
Number of subjects: 90
Study: 28619989

Group type: EXPERIMENTAL
Intervention: Low-dose alteplase (0.6 mg/kg)
Number of subjects: 752

Group type: COMPARATOR
Intervention: Standard-dose alteplase (0.9 mg/kg)
Number of subjects: 752

Group type: EXPERIMENTAL
Intervention: Alteplase (both doses)
Number of subjects: 752
Study: 25872171

Group type: EXPERIMENTAL
Intervention: Standard therapy plus lornoxicam
Number of subjects: 334

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 334
Study: 24013940

Group type: EXPERIMENTAL
Intervention: Stair-jump exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Level-jump exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 0
Study: 21377715

Group type: EXPERIMENTAL
Intervention: High-fat meal (48% fat, 49 g)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Low-fat meal (15% fat, 3 g)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: High-trans fatty acid meal (5.2 g trans fat)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Nontrans fatty acid meal (<0.3 g trans fat)
Number of subjects: 66
Study: 19424036

Group type: EXPERIMENTAL
Intervention: Standard-dose cyclosporine A (CsA; 150-300 ng/mL for 3 months then 100-200 ng/mL)
Number of subjects: 1645

Group type: EXPERIMENTAL
Intervention: Low-dose cyclosporine A (CsA; 50-100 ng/mL)
Number of subjects: 1645

Group type: EXPERIMENTAL
Intervention: Low-dose tacrolimus (Tac; 3-7 ng/mL)
Number of subjects: 1645

Group type: EXPERIMENTAL
Intervention: Low-dose sirolimus (SRL; 4-8 ng/mL)
Number of subjects: 1645
Study: 17896302

Group type: EXPERIMENTAL
Intervention: Progressive addition lenses (PALs)
Number of subjects: 469

Group type: COMPARATOR
Intervention: Single vision lenses (SVLs)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Parental myopia
Number of subjects: 469
Study: 15098129

Group type: EXPERIMENTAL
Intervention: Active cool-down (AC)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Passive cool-down (PC)
Number of subjects: 10
Study: 11817530

Group type: EXPERIMENTAL
Intervention: Mannitol 4 g/l
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Mannitol 8 g/l
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no mannitol)
Number of subjects: 33
Study: 9817093

Group type: EXPERIMENTAL
Intervention: Power Doppler ultrasound
Number of subjects: 50

Group type: COMPARATOR
Intervention: Venography (gold standard)
Number of subjects: 50
Study: 7624494

Group type: EXPERIMENTAL
Intervention: Desipramine treatment
Number of subjects: 21
Study: 2677092

Group type: EXPERIMENTAL
Intervention: HMW-GOID
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Standardized orchard grass-pollen extract
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: GOID
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 357456

Group type: EXPERIMENTAL
Intervention: Diphenhydramine (12.5, 25, or 50 mg)
Number of subjects: 1295

Group type: EXPERIMENTAL
Intervention: Methapyrilene (36, 72, or 144 mg)
Number of subjects: 1295

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1295
Study: 31309737

Group type: EXPERIMENTAL
Intervention: Core outcome set for systemic sclerosis (SSc) trials
Number of subjects: 4193

Group type: EXPERIMENTAL
Intervention: CRISS measures
Number of subjects: 4193

Group type: EXPERIMENTAL
Intervention: Health-related quality of life (HRQoL) and function
Number of subjects: 4193

Group type: EXPERIMENTAL
Intervention: Skin outcomes
Number of subjects: 4193

Group type: EXPERIMENTAL
Intervention: Pulmonary outcomes
Number of subjects: 4193
Study: 30611592

Group type: EXPERIMENTAL
Intervention: Low‐cost self‐made arthroscopic camera (LAC)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Commercial arthroscopic camera (CAC)
Number of subjects: 153
Study: 29182634

Group type: EXPERIMENTAL
Intervention: Direct provision of HIV self-tests
Number of subjects: 960

Group type: COMPARATOR
Intervention: Standard of care HIV testing
Number of subjects: 960
Study: 25523888

Group type: EXPERIMENTAL
Intervention: FDA scoring system for fentanyl TDS adhesion
Number of subjects: 30
Study: 23619951

Group type: EXPERIMENTAL
Intervention: Multi-component higher-functioning autism anti-stigma program
Number of subjects: 395

Group type: COMPARATOR
Intervention: No-intervention peer condition
Number of subjects: 395

Group type: COMPARATOR
Intervention: No-intervention non-peer condition
Number of subjects: 395
Study: 21818354

Group type: EXPERIMENTAL
Intervention: 20 Hz rTMS over the DLPFC
Number of subjects: 24

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 24
Study: 19781403

Group type: EXPERIMENTAL
Intervention: ivabradine
Number of subjects: 4954
Study: 16936159

Group type: EXPERIMENTAL
Intervention: Acarbose 100 mg t.i.d.
Number of subjects: 219

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study: 14769097

Group type: EXPERIMENTAL
Intervention: Hierarchical expectancy model
Number of subjects: 0
Study: 10966893

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation
Number of subjects: 295
Study: 8828671

Group type: EXPERIMENTAL
Intervention: 12% O2
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 21% O2
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 100% O2
Number of subjects: 11
Study: 1916978

Group type: EXPERIMENTAL
Intervention: Peribulbar anaesthesia
Number of subjects: 142

Group type: COMPARATOR
Intervention: Retrobulbar anaesthesia
Number of subjects: 142
Study: 7058839

Group type: EXPERIMENTAL
Intervention: Inhaled isoproterenol alone
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Isoproterenol plus intravenous aminophylline
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Isoproterenol plus a single oral dose of an elixir of theophylline
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Injectable sympathomimetic agent (given if treatment beyond 60 minutes was required)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Severity of obstruction at presentation
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Initial 1‐second forced expiratory volumes less than 30 percent of predicted
Number of subjects: 102
Study: 30220556

Group type: EXPERIMENTAL
Intervention: Unilateral VIM DBS
Number of subjects: 119

Group type: COMPARATOR
Intervention: Staged bilateral DBS
Number of subjects: 119
Study: 27618471

Group type: EXPERIMENTAL
Intervention: Contrast loading protocol (3 bench-throws with 30% load of 1RM, conditioning set of 5 bench-throws with 60% load of 1RM, followed by 2 sets of 3 bench-throws with 30% load of 1RM)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control protocol (3 sets of 3 bench-throws with 30% load of 1RM)
Number of subjects: 11
Study: 25200037

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg orally 1 hour prior to induction of anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 25074944

Group type: EXPERIMENTAL
Intervention: High-Intensity Noninvasive Ventilation (HI-NIV)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Target Tidal Volume Noninvasive Ventilation (target V(T) NIV)
Number of subjects: 14
Study: 22459631

Group type: EXPERIMENTAL
Intervention: Warm medium prewarmed to 37°C
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cold medium at room temperature
Number of subjects: 200
Study: 20923841

Group type: EXPERIMENTAL
Intervention: Midwife care
Number of subjects: 1708

Group type: EXPERIMENTAL
Intervention: GP parallel testing
Number of subjects: 1708

Group type: EXPERIMENTAL
Intervention: GP sequential testing
Number of subjects: 1708
Study: 19016089

Group type: EXPERIMENTAL
Intervention: Relapse Prevention Therapy (RPT)
Number of subjects: 0
Study: 15934028

Group type: EXPERIMENTAL
Intervention: WS®1490 (kava-kava extract)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12044531

Group type: EXPERIMENTAL
Intervention: LAM/IFN combination therapy (IFN at 5MU t.i.w. + LAM at 100mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: LAM monotherapy (LAM at 100mg/day)
Number of subjects: 50
Study: 10527090

Group type: EXPERIMENTAL
Intervention: Isokinetic exercise of the quadriceps muscle three times weekly over 8 weeks
Number of subjects: 113

Group type: COMPARATOR
Intervention: Educational intervention (4 discussions and lectures led by health care professionals)
Number of subjects: 113
Study: 8821072

Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dopamine-agonists
Number of subjects: 0
Study: 2626285

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg for children younger than 12 years and 12 mg for adults every 12 hours for 3 days) in addition to standard antibacterial chemotherapy (ampicillin and chloramphenicol)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 429

Group type: COMPARATOR
Intervention: Control group (antibacterial chemotherapy alone)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Dexamethasone and Control group
Number of subjects: 429
Study: 1105112

Group type: EXPERIMENTAL
Intervention: Gentamicin (80 mg intramuscular injection at the time of anaesthetic premedication)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 80
Study: 30601999

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (500 IU/day)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study: 29319061

Group type: EXPERIMENTAL
Intervention: Xylitol gum plus oral health education
Number of subjects: 174

Group type: COMPARATOR
Intervention: Oral health education alone
Number of subjects: 174